Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart surgery patients given carb drink show better insulin response

NCT ID NCT07212153

Symptom relief Sponsor: Rifdhani Fakhrudin Nur Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether drinking a carbohydrate beverage two hours before cardiac surgery could lower insulin resistance, a condition that can raise blood sugar and slow recovery. Fifty adults undergoing heart surgery were randomly assigned to receive either a maltodextrin drink or plain water. Researchers measured insulin and glucose levels before and after surgery to compare the effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Maltodextrin (carbohydrate drink)
What this could lead to
If it works, this could lead to a simple, low-cost way to reduce insulin resistance and speed recovery after heart surgery.
What could go wrong
This is a small, completed trial with only 50 participants. Results may not apply to people with diabetes or other conditions, and the benefit may be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Jan 2024

Finished

May 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Age 20 to 60 years * ASA physical status II or III * Good tolerance to enteral fluid administration Exclusion criteria: * History of diabetes mellitus * Thyroid insufficiency * Adrenal insufficiency * Gastroesophageal reflux disease * Emergency cardiac surgery Dropout criteria: * Participant withdraws consent * Cardiac surgery duration exceeds 4 hours

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac surgery Insulin resistance

Contacts and locations

Locations

  • RSUP Dr. Sardjito

    Sleman, D.I.Yogyakarta, 55281, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.